On December 6, 2024, BioAge announced that it would discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag after liver transaminitis was observed in some ...
the potential for liver transaminitis in any of its previous clinical Phase 1 trials and various preclinical tox studies; (2) potential safety concerns with the Company's ongoing STRIDES clinical ...
Specifically, Defendants misrepresented and/or failed to disclose: (1) the potential for liver transaminitis in any of its previous clinical STRIDES Phase 1 trials and various preclinical tox ...
A yearlong outbreak of tuberculosis in the Kansas City, Kansas area has taken local experts aback, even if it does not appear ...
As Kansas deals with one of the largest tuberculous outbreaks in the nation since the 1950s, Californians may be wondering ...
Glucarpidase treatment significantly improves kidney recovery odds and reduces risks of neutropenia and transaminitis in MTX-AKI patients ... Cancer-related disease progression was the most common ...
Virtually nothing is known about the Kansas tuberculosis outbreak. This disease surpassed COVID as the leading disease cause ...
However, most people get infected with TB don’t get sick, according to NCDHSS. That’s because their bodies can fight the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback